International Journal of Home Science
2021, VOL. 7 ISSUE 3, PART C
Abdominal obesity and health risk
Author(s): Jaiswal Apoorva, Dr. Paul Virginia and Afreen Sana
Abdominal fat or truncal obesity consists of both subcutaneous and visceral fat. It has been found that visceral fat is more metabolically active than subcutaneous fat. The low-level inflammation linked with abdominal fat is associated with insulin resistance and with increases in the release of inflammatory adipokines and cytokines. As a result of these changes, abdominal fat can cause a variety of health conditions. In this review, we focus on the adverse effects of abdominal fat on the body and how it can lead to the development of cardiovascular disease, hypertension, type 2 diabetes mellitus, hyperlipidemia, stroke and cancer. Additionally, we discuss how abdominal fat can be reduced as a result from correction of hormonal deficiencies. Abdominal (visceral) obesity is thought to be the predominant risk factor for metabolic syndrome and as predictions estimate that 50% of adults will be classified as obese by 2030 it is likely that metabolic syndrome will be a significant problem for health services and a drain on health economies. The most widely used measures for abdominal obesity include waist circumference (WC) and waist-to-hip ratio (WHR), which are determined by both environmental and genetic factors.
How to cite this article:
Jaiswal Apoorva, Dr. Paul Virginia, Afreen Sana. Abdominal obesity and health risk. Int J Home Sci 2021;7(3):152-155.